DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ultram ER (Tramadol Hydrochloride) - Summary

 
 



ULTRAM ER SUMMARY

ULTRAM® ER (tramadol hydrochloride) is a centrally acting synthetic analgesic in an extended-release formulation.

ULTRAM ER is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.


See all Ultram ER indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Ultram ER (Tramadol)

AAFP to Tackle Climate Change, Drug Prices, Pain in Orlando
Source: Medscape Medical News Headlines [2016.09.16]
A resolution calling for a Surgeon General's report on gun violence and another on remaining neutral about physician-assisted suicide will be among the issues considered at the Congress of Delegates.
Medscape Medical News

Kids and Pain: FDA Considers Rules for Pediatric Opioid Trials
Source: MedPage Today Neurology [2016.09.15]
(MedPage Today) -- Study is needed, but how should it be done?

Illicit Substance Use in US Adults With Chronic Back Pain
Source: Medscape Anesthesiology Headlines [2016.09.14]
Some chronic low back pain sufferers may resort to the use of illicit drugs to find pain relief. How prevalent is the problem?
Spine

Vulnerability to Chronic Pain and Resistance to Analgesia
Source: Medscape Anesthesiology Headlines [2016.09.14]
Why do some people develop chronic pain while others don't? Neuroimaging studies suggest that corticolimbic networks involved with reward and learning might provide a neurophysiological explanation.
Brain

Higher Costs Associated With TKR in Obese, Anxious Patients: The Pain Medicine News Report
Source: MedPage Today Pediatrics [2016.09.14]
(MedPage Today) -- Also, Facebook for inflammatory back pain outreach?

more news >>

Published Studies Related to Ultram ER (Tramadol)

Does the addition of tramadol and ketamine to ropivacaine prolong the axillary brachial plexus block? [2014]
ropivacaine in brachial plexus anesthesia... CONCLUSION: We conclude that when added to brachial plexus analgesia at a dose of

Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial. [2013]
whether cessation of ER tramadol produces opioid withdrawal... CONCLUSIONS: ER tramadol 200mg modestly attenuated opioid withdrawal. Mild opioid

Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. [2012]
on pain during insertion of an intrauterine device (IUD)... CONCLUSION: Prophylactic analgesia using 50 mg tramadol and 550 mg naproxen,

Tramadol versus methadone for treatment of opiate withdrawal: a double-blind, randomized, clinical trial. [2012]
The aim of this study was to compare the efficacy and safety of tramadol versus methadone for treatment of opiate withdrawal. Seventy patients randomly were assigned in two groups to receive either prescribed methadone (60 mg/day) or tramadol (600 mg/day)... Tramadol may be as effective as methadone in the control of withdrawal and could be considered as a potential substitute for methadone to manage opioids withdrawal.

Comparison of peritonsillar infiltration effects of ketamine and tramadol on post tonsillectomy pain: a double-blinded randomized placebo-controlled clinical trial. [2012]
on post tonsillectomy pain and compare the side effects... CONCLUSION: Preoperative peritonsillar infiltration of tramadol can decrease

more studies >>

Clinical Trials Related to Ultram ER (Tramadol)

Postoperative Tramadol/Gabapentin/Ibuprofen Versus Tramadol/Placebo/Ibuprofen [Recruiting]
Tonsillectomy is the most common pediatric surgical procedure performed in the US, with over 530,000 procedures performed annually in children under 15 years (Baugh et al., 2011). The postoperative period can be particularly painful. A recent clinical consensus acknowledges there is no standard analgesic protocol, and calls for further research comparing postoperative pain medications (Baugh et al., 2011). Tramadol was found to be as effective as codeine with few reported side effects in a recent double-blinded, controlled trial conducted by the investigators at Children's Hospitals and Clinics (CHC), and it is currently being prescribed in the postoperative setting. However, despite its effectiveness for pain control, there were some children that continued to report pain during the 10-day follow-up period. In response, the investigators will conduct a randomized, double-blinded controlled trial to determine whether or not adding scheduled gabapentin to a scheduled tramadol + "as needed" (PRN) ibuprofen regimen provides better pain control than tramadol + ibuprofen PRN alone during the post-tonsillectomy period. Using a 10-day take-home diary, caregivers will be asked to record daily information about their child's postoperative pain and other core outcomes and domains as recommended in the recent consensus statement put forth by the Pediatric Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) (McGrath et al., 2008). This study will offer new information regarding the efficacy and side effects associated with adding scheduled gabapentin to a postoperative pain management protocol in a pediatric population.

A Comparison of Postoperative Tramadol Versus Acetaminophen With Codeine in Children Undergoing Tonsillectomy [Completed]
Tonsillectomy is the most common pediatric surgical procedure performed in the US. The postoperative period can be particularly painful. Codeine (usually in mixed formulation with acetaminophen) is the most commonly prescribed opioid in the US. However, evolving data questions its ability to provide optimal pain relief, while avoiding side effects, especially in the postoperative setting. Tramadol may be a better option for children in the postoperative setting due to its well-documented analgesic properties, low potential for side effects, and excellent safety profile. Seventy-two children scheduled to undergo tonsillectomy (with or without adenoidectomy) at Children's will be invited to participate in a randomized, prospective, double-blinded study to evaluate the efficacy and side effects of codeine with acetaminophen versus tramadol. Using a 10-day take-home diary, caregivers will be asked to record daily information about their child's postoperative pain and other core outcomes and domains as recommended in the recent consensus statement put forth by the Pediatric Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) (McGrath et al., 2008). This study will offer new information regarding the efficacy and side effects associated with tramadol as compared with codeine/acetaminophen (the current practice standard) in a pediatric population. Hypotheses H1: Children who receive scheduled tramadol following tonsillectomy will report better pain control than children who receive scheduled codeine/acetaminophen. H2: Children who receive scheduled tramadol following tonsillectomy will report fewer side effects than children who receive scheduled codeine/acetaminophen.

The Effect of Escitalopram on the Pharmacokinetics and Pharmacodynamics of Tramadol in Healthy Subjects [Completed]
Escitalopram will be given to a panel of 16 healthy subject for 9 days. On the ninth day a single dose of tramadol is administered to the subjects and pharmacokinetic(PK) and pharmacodynamic(PD) measurements are done for the next 24 hours. It is stated that escitalopram is only a weak inhibitor of CYP2D6 and therefore no effect is seen in Pk or PK of tramadol

A Pharmacokinetic Study to Evaluate the Dose-Proportionality of Tramadol (ULTRAM) Extended-Release (ER) in Healthy Participants [Completed]
The purpose of this study is to evaluate the dose proportionality of the pharmacokinetics (explores what the body does to the drug) of tramadol in healthy adult participants.

A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers [Completed]
The purpose of this study is to determine the safety and tolerability profile of tramadol hydrochloride (HCl) given as oral doses every 6 hours, within the range of dosages supported by currently available toxicology and clinical data (200 mg to 600 mg per day).

more trials >>

Reports of Suspected Ultram ER (Tramadol) Side Effects

Drug Ineffective (5)Hypersensitivity (3)Pruritus (3)Pain (3)Skin Burning Sensation (3)Myalgia (3)Hypersomnia (3)Arthralgia (3)Drug Dose Omission (2)Neck Pain (2)more >>


PATIENT REVIEWS / RATINGS / COMMENTS

Based on a total of 2 ratings/reviews, Ultram ER has an overall score of 5.50. The effectiveness score is 6 and the side effect score is 9. The scores are on ten point scale: 10 - best, 1 - worst.
 

Ultram ER review by 29 year old male patient

  Rating
Overall rating:  
Effectiveness:   Highly Effective
Side effects:   Mild Side Effects
  
Treatment Info
Condition / reason:   Cervical Disk Degeneration and Lower Back Pain
Dosage & duration:   50mg every 6 hrs as needed taken 2-3 times a day for the period of been taking for 2 weeks now.
Other conditions:   Tinitus, Unable to sleep
Other drugs taken:   Ambien
  
Reported Results
Benefits:   Ive been taking Tramadol for 2 weeks now. Ive been taking vicodin and percocuet for 7 months due to Cervial disk degeneration and lower back pain. I have to admit I loved taking Vicodin and percocuet. The problem is that they would knock me out. Tramadol has been awesome. It takes 90% of the pain away and I feel like I actually have energy again. From reading previous comments it sounds like I take a lower dose. Im really happy about that cause if I get use to it then I can up my dose and not feel worried about it.
Side effects:   I have had no side effects so far. I hope it stays that way.
Comments:   Treating for neck, shoulder, arms, lower back, hip, thigh and knee pain.

 

Ultram ER review by 34 year old female patient

  Rating
Overall rating:  
Effectiveness:   Ineffective
Side effects:   No Side Effects
  
Treatment Info
Condition / reason:   Pain relief from an infected cat bite wound
Dosage & duration:   200mg taken once daily for the period of 2 days
Other conditions:   none
Other drugs taken:   Levaquin, Promethazine
  
Reported Results
Benefits:   I was not able to ascertain any benefits from being treated with this medication. Its purpose was pain relief, and I did not experience any alleviation of my pain.
Side effects:   I did not experience any side effects from taking this medication.
Comments:   I was prescribed this medication after being seen by a doctor for a severely infected cat bite wound on the top of my left foot (which the doctor was concerned might become a systemic infection). The foot and my entire left leg were very painful (especially upon movement), so the doctor had me take Ultram ER to help relieve the pain. I was told to take 1 tablet daily as needed. I did as instructed for two consecutive days and did not have any relief from my pain. After I reported this to my doctor, she gave me a prescription for a stronger pain reliever (which did help).

See all Ultram ER reviews / ratings >>

Page last updated: 2016-09-16

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015